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Peripheral arterial occlusive disease has been
found to correlate with alterations in blood and plas-
ma viscosity,1,2 whereas preoperative values did not
affect the outcome of infrainguinal bypass grafting.3
After successful infrainguinal bypass grafting,
Woodburn et al4 found that the relative blood vis-
cosity, as a measure of erythrocyte rigidity, decreased
and that the corrected blood viscosity only showed a
tendency to decrease, whereas hematocrit was unaf-
fected. In their experiment, the postoperative blood
rheologic features were comparable with those of
age-matched control subjects. However, no investi-
gation has been performed that elucidates potential
differences between hemorheologic variables in
blood in the general circulation versus blood drain-
ing the limb with critical ischemia. In a recent review
of hemorheologic changes during human aging,5
fibrinogen, plasma viscosity, and red cell aggregation
were reported to increase, and red cell deformability
was reported to decrease with increasing age.
The aim of this study was to investigate hemor-
heologic variables in patients with critical limb
ischemia (CLI) before and 1 month after infrain-
guinal reconstruction, both in blood from the gen-
eral circulation and in blood draining the affected
limb. A comparison was also made with a control
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Purpose: Plasma and whole blood viscosity are elevated in patients with intermittent clau-
dication. The objectives of this study were to investigate whether critical limb ischemia
influences hemorheologic variables and whether the rheologic variables in blood from
the affected limb differ from the general circulation. We also intended to study whether
successful infrainguinal reconstruction improved hemorheologic variables.
Methods: Ten consecutive patients with critical limb ischemia (CLI) underwent arterial
reconstruction, one patient with profundaplasty and nine patients with bypass procedures.
Venous blood was sampled from the antecubital vein (arm) and the femoral vein (leg) of
the affected limb 1 day before and 1 month after surgery. Ten control subjects (matched
according to age, sex, diabetic status, and renal insufficiency) were also sampled. Whole
blood viscosity, plasma viscosity, erythrocyte aggregation tendency, and erythrocyte fluid-
ity (the latter variable describing the deformability of the erythrocytes) were measured by
means of rotational viscometry. Erythrocyte volume fraction was also determined.
Fibrinogen was measured in the patients with CLI.
Results: Erythrocyte fluidity, blood viscosity, and erythrocyte volume fraction were lower
in patients with CLI than in control subjects (P < .01, P < .01, and P < .05, respective-
ly). No major differences between cubital and femoral vein blood were seen before or
after the operation in patients with CLI or in control subjects. Successful revasculariza-
tion did not influence the hemorheologic variables, except for a decrease in blood vis-
cosity in femoral vein blood (P < .05).
Conclusion: Hemorheologic properties was impaired in patients with CLI. Because no
differences were seen between the systemic and local circulation and because no major
improvement occurred 1 month after arterial reconstruction, other mechanisms besides
local tissue ischemia may play a role. (J Vasc Surg 2000;31:691-5.)
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group that was matched according to age, sex, dia-
betic status, and renal insufficiency.
MATERIAL AND METHODS
Approval for this study was obtained from the
research ethics committee, Faculty of Medicine,
University of Uppsala. Patients and control subjects
gave their approval after receiving verbal and written
information.
Patients. Ten patients (six men and four
women) with a median age of 71 years (range, 52-
85 years) had CLI. Except for two patients with false
high pressures because of incompressible vessels, the
median ankle brachial pressure index was 0.24
(range, 0-0.6). Seven patients had rest pain and noc-
turnal pain, and seven patients had arterial ulcers.
Five patients had diabetes; three patients had a his-
tory of coronary arterial disease; two patients had
sequelae after cerebrovascular lesion; three patients
were receiving medication for hypertension, and one
patient was dependent on hemodialysis. Six patients
were smokers. Exclusion criteria were malignancies,
inflammatory disease, and medication with warfarin
before or after an operation. Nine infrainguinal by-
pass graftings (seven vein and two polytetrafluo-
roethylene) and one profundaplasty were per-
formed. After the operation, all patients received
160 mg of acetyl salicylic acid daily.
Control population. Ten volunteers without
clinical signs of peripheral arterial occlusive disease
(six men and four women; median age, 74.5 years;
range, 52-78 years) were used as control subjects for
all variables. Five of these patients had diabetes, and
one patient had renal insufficiency and was depen-
dent on hemodialysis.
Blood sampling. Patients with CLI were sam-
pled 1 day before surgery and 1 month after success-
ful reconstruction. The control subjects were sam-
pled once. In these two groups, blood was harvested
both from the antecubital vein and the femoral vein
(from the affected limb in patients with CLI) and
collected in dry-heparinized vacutainer tubes
(Terumo Venoject, Leuven, Belgium). A tourniquet
was used during sampling from the antecubital vein
because our reference values were calculated from
blood harvested under similar conditions,6 and
duplex scanning was used to guide puncture of the
femoral vein.
Rheologic analyses. All rheologic analyses were
performed by the same investigator (B.S.). A
Couette rotational viscometer (Low Shear 30;
Contraves AG, Zürich, Switzerland) with a 1 to 1
couette (bob-in-cup) system was used at 37°C.7
Whole blood viscosity was measured at shear rates of
100 seconds–1 and 1 seconds–1. Whole blood viscos-
ity at high shear rate represented whole blood appar-
ent viscosity (BV; reference values: median, 4.58;
minimum-maximum, 3.60-5.63 MPa × second); at
the low shear rate, the whole blood viscosity is main-
ly dependent on erythrocyte aggregation why 
erythrocyte aggregation tendency (AG; reference
values: median, 0.98; min-max, 0.76-1.26 MPa ×
second) could be calculated by correction for eryth-
rocyte volume fraction (EVF) and plasma viscosity
(PV). The unit for AG is dimensionless. PV was ana-
lyzed at a shear rate of 38 seconds–1 (reference val-
ues: median, 1.30; minimum-maximum, 1.16-1.49
MPa × second). The intra-assay and interassay coef-
ficients of variability for BV were 0.9% and 2.6%, for
AG were 1.4% and 7.9%, and for PV were 0.7% and
3.1%, respectively.6 Erythrocyte fluidity (Pa–1 × sec-
ond–1) was determined with a modification of the
original method with the use of only one centrifuga-
tion of whole blood instead of washing of the eryth-
rocytes and then pipetting off the plasma and buffy
coat, resuspending the erythrocytes in buffer to a
standardized EVF of 55%, and immediately measur-
ing the viscosity at a shear rate of 1.0 second–1.8
Erythrocyte fluidity was expressed as the inverted
value of the erythrocyte viscosity (reference values:
median, 103.3; minimum-maximum, 75.1-127.1
MPa × second), measured in pascal–1 × second–1.
Intra-assay coefficient of variability for erythrocyte
fluidity was calculated to be 4.9%.
EVF. EVF was analyzed by microhematocrit
centrifugation at 11000g for 5 minutes without cor-
rection for trapped plasma.
Fibrinogen assay. Quantitative determination of
fibrinogen levels in plasma was performed by the
clotting method of Clauss (Fibri-Prest Automat 2;
Triolab AB, Diagnostica Stago, Asnieres-sur-Seine,
France). Reference interval in our laboratory was
2.0-3.6 g/L. Coefficient of variation was 8% or less.
Statistics. Variables are presented as median and
minimum-maximum, unless otherwise stated. Wilcoxon
signed rank test was used for the comparison of the
results before and after reconstructive surgery. Com-
parisons between groups were made with the Mann-
Whitney U test. Results were presented as two-tailed
level of probability; a P value of less than .05 was con-
sidered significant.
RESULTS
Arm versus leg. Except for lower values for
whole BV because of the lower EVF and in femoral
blood than in cubital blood 1 month after surgery
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(P < .05, for both), no differences were found
among patients with CLI. The control subjects
showed a lower EVF in femoral blood than in
cubital blood (P < .05). Because there were only
minimal differences in leg and arm vein blood, we
preferred (to make it easier to compare patients and
control subjects) to present and compare just the
values of arm vein blood.
CLI versus control subjects. EVF was lower in
CLI than in control subjects (P < .05); whole BV
also was lower in patients with CLI (P < .01; Table
I). PV and AG did not differ between patients with
CLI and control subjects. Erythrocyte fluidity was
significantly lower in patients with CLI than in con-
trol subjects (P < .01). There was no significant dif-
ference in fibrinogen concentration when seven of
the patients with CLI were compared with six of the
control subjects who had diabetes and renal insuffi-
ciency (5.62 g/L [3.50-7.09] vs 3.9 g/L [3.6-6.3]).
Both patients with CLI and control subjects were
higher than the reference interval of our laboratory
(2.0-3.6 g/L).
CLI before surgery versus CLI after surgery.
Whole BV was lower in femoral blood 1 month after
surgery than before surgery (P < .05; Table II). No
other differences were seen.
DISCUSSION
Whole BV, erythrocyte fluidity (corresponding
to erythrocyte deformability), and EVF all differed
significantly between patients with CLI (both before
and after the operation) and control subjects, who
were matched according to sex, age, diabetic status,
and renal insufficiency. Because the groups consisted
of only 10 patients and 10 control subjects, the sta-
tistical power in this study is low for small differ-
ences. However, there were three significant changes
between patients and control subjects. These
changes indicated impaired flow properties in CLI
with a possible subsequent decrease in the transport
of oxygen and nutritive substances to the tissues and
reduced removal of metabolites from the tissues.
Moreover, in a comparison between the patients
with CLI and 83 healthy subjects6 with a median age
of 38 years, EVF was lower, PV was higher, whole
BV was lower, AG was higher, and erythrocyte flu-
idity was lower in patients with CLI (data not
shown). These data support the findings that
hemorheologic variables are abnormal in patients
with CLI.
Only whole BV in the blood draining the
ischemic and revascularized limb was significantly
altered 1 month after successful revascularization,
indicating no major improvement of hemorheologic
variables after infrainguinal arterial reconstruction.
The use of low shear rate rotational viscometer7
differed from previous measurements of hemorheo-
logic variables in peripheral arteriosclerotic occlusive
disease1 with the use of a capillary viscometer
(Coulter-Harkness) for measuring blood and PV. In
a comparison of five different methods for estimat-
ing the degree of AG, viscometry together with the
sedimentation test and the Paar device showed the
highest range of response and sensitivity.17 When
the capillary viscometer erythrocyte fluidity was used
as a measure of erythrocyte deformability, erythro-
cyte deformability was calculated by a correction of
the blood viscosity for the effects of hematocrit and
PV. In the rotational viscometer, erythrocyte fluidi-
ty was measured in a more direct way by the inver-
sion of erythrocyte viscosity at a standardized EVF
of 55% in a buffer at a low shear rate. Viscometric
methods have been mentioned by the International
Committee of Standardization in Haematology as
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Table I. Patients with CLI versus control subjects
Patients with 
Variable CLI before surgery Control subjects
EVF (%) 38.6 (29.2-50.4) 44.4 (39.4-49.6)*
PV (MPa × sec) 1.37 (1.34-1.85) 1.34 (1.2-1.7)†
BV (MPa × sec) 4.03 (3.37-5.40) 4.68 (4.06-5.26)‡
AG 1.22 (0.92-1.43) 1.11 (0.92-1.68)§
EF (Pa–1 × sec–1)|| 97.8 (86.3-108.2) 111.5 (81.6-125.9)‡
The values are expressed as medians (minimum-maximum).
*P < .05.
†P = .19; not significant.
‡P < .01; the Mann-Whitney U test was used for comparison of
the two independent groups.
§P = .3150; not significant.
||Represents erythrocyte deformability.
Table II. Preoperative versus postoperative values
in patients with CLI
Preoperative Postoperative 
Variable values values
EVF (%) 38.6 (29.2-50.4) 39.0 (33.4-49.2)*
PV (MPa × sec) 1.37 (1.34-1.85) 1.40 (1.22-1.55)*
BV (MPa × sec) 4.03 (3.37-5.40) 3.86 (3.64-4.80)*
AG 1.22 (0.92-1.43) 1.21 (0.96-1.39)*
EF (Pa–1 × sec–1)† 97.8 (86.3-108.2) 99.5 (76.7-122.1)*
The values are expressed as median (minimum-maximum). The
Wilcoxon signed rank test was used for comparing repeated mea-
surement.
*Not significant.
†Represents erythrocyte deformability.
one method for measuring erythrocyte fluidity.9
In contrast to other studies10-12 we could not
establish any significant correlation between age and
hemorheologic variables when we analyzed our ref-
erence group and control group together (data not
shown). Moreover, there were no differences in PV,
BV, or AG between the reference group of 83 sub-
jects with a median age of 38 years and the control
group of 10 subjects with a median age of 74.5
years. These diverging results may be explained by
differences in population size or different methods
used; actually, such a correlation still remains to be
determined.
Alterations of hemorheologic variables may
depend on the existence of arteriosclerosis2,4,13 and
with early lesions,14 diabetes,15 hypertension,16 and
renal insufficiency. In our study, a large proportion
of the patients experienced various manifestations of
arteriosclerosis, diabetes mellitus, and hypertension;
one patient was dependent on hemodialysis. To
compensate for these factors, we used a control
group that was matched for age, sex, diabetic status,
and hemodialysis. However, the hemorheologic
impairment caused by CLI alone may be difficult to
assess. There were findings that the only significant
change between preoperative and postoperative rhe-
ologic variables was a postoperative decrease in
whole BV in femoral blood; the lack of difference
between cubital and femoral blood may indicate that
factors other than tissue ischemia caused impaired
blood rheologic conditions or that the local tissue
ischemia induces a generalized effect on rheologic
variables.
The lack of major rheologic improvement after
arterial reconstruction is supported by Woodburn et
al.4 The decreased values of whole blood viscosity
and EVF compared with control subjects are contra-
dicting findings concerning claudicants1 and the
early stages of atherosclerosis.14 There are also stud-
ies that indicate unaltered BV and EVF in claudi-
cants compared with control subjects2 and decreases
of BV and EVF that vary with the angiographic
extent of peripheral arterial disease.4
The erythrocyte fluidity decrease in patients with
CLI persisted after revascularization, which indicat-
ed a chronic nature of erythrocyte pathologic fea-
tures that may explain an increased destruction of
large and stiff erythrocytes that are unable to pass
through the narrow filters of the spleen with the
subsequent decrease in EVF observed in this study.
With a linear increase in EVF, there is an expo-
nential increase in whole blood viscosity18 that may
explain the decreases in both of these variables in
patients with CLI compared with control subjects.
PV has been shown to increase with the severity
of arteriosclerosis13 and in claudicants.1,2 A correla-
tion has been found between fibrinogen and PV.10
Our study did not show any differences in PV or fi-
brinogen between the groups, which supports the
latter relationship. However, the small sample size
makes these observations uncertain.
In conclusion, because the impaired hemorheo-
logic variables in patients with CLI seem to be of
long duration and not immediately relieved by arte-
rial reconstruction, they may have a multifactorial
cause and not be caused by tissue ischemia only.
Future studies of the hemorheologic effects of
drugs that improve graft patency would be of great
interest.
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